TEICOPLANIN

被引：28

作者：

SHEA, KW

CUNHA, BA

机构：

[1] WINTHROP UNIV HOSP, DIV INFECT DIS, MINEOLA, NY 11501 USA

[2] SUNY STONY BROOK, SCH MED, STONY BROOK, NY 11794 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1995年 / 79卷 / 04期

关键词：

D O I：

10.1016/S0025-7125(16)30042-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Teicoplanin, a new glycopeptide antibiotic similar to vancomycin, has proven effective in the treatment of various gram-positive infections in both the normal and the immunocompromised host. In vitro activity against most gram-positive organisms is equal to or greater than that of vancomycin. Favorable pharmacokinetics allow for intramuscular administration as well as intravenous bolus dosing; maintenance therapy may be given on a once-daily basis after appropriate loading doses. The combination of all these factors makes teicoplanin an effective and safe alternative to vancomycin in the treatment of gram-positive infections.

引用

收藏

页码：833 / 844

页数：12

相关论文

共 53 条

[1] COMPARISON OF THE ACTIVITIES OF COUMERMYCIN, CIPROFLOXACIN, TEICOPLANIN, AND OTHER NON-BETA-LACTAM ANTIBIOTICS AGAINST CLINICAL ISOLATES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS FROM VARIOUS GEOGRAPHICAL LOCATIONS [J].

ALDRIDGE, KE ;

JANNEY, A ;

SANDERS, CV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :634-638

[2] SUSCEPTIBILITY OF PENICILLIN-SENSITIVE AND PENICILLIN-RESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE TO NEW ANTIMICROBIAL AGENTS, INCLUDING DAPTOMYCIN, TEICOPLANIN, CEFPODOXIME AND QUINOLONES [J].

APPELBAUM, PC ;

SPANGLER, SK ;

CROTTY, E ;

JACOBS, MR .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (04) :509-516

[3] SUSCEPTIBILITY OF STAPHYLOCOCCUS SPECIES AND SUBSPECIES TO TEICOPLANIN [J].

BANNERMAN, TL ;

WADIAK, DL ;

KLOOS, WE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1919-1922

[4] EFFICACY AND PHARMACOKINETICS OF TEICOPLANIN IN HEMODIALYSIS-PATIENTS [J].

BECKERS, B ;

BRODERSEN, HP ;

STOLPMANN, RM ;

JANSEN, G ;

LARBIG, D .

INFECTION, 1993, 21 (01) :71-74

[5] TEICOPLANIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL [J].

CAMPOLIRICHARDS, DM ;

BROGDEN, RN ;

FAULDS, D .

DRUGS, 1990, 40 (03) :449-486

[6] PHARMACOKINETICS OF SINGLE-DOSE AND MULTIPLE-DOSE TEICOPLANIN IN HEALTHY-VOLUNTEERS [J].

CARVER, PL ;

NIGHTINGALE, CH ;

QUINTILIANI, R ;

SWEENEY, K ;

STEVENS, RC ;

MADERAZO, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :82-86

[7] INVITRO EVALUATION OF CEFPIROME (HR 810), TEICOPLANIN AND 4 OTHER ANTIMICROBIALS AGAINST ENTEROCOCCI [J].

CHANDRASEKAR, PH ;

PRICE, S ;

LEVINE, DP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (02) :179-182

[8]

CHOW AW, 1993, EUR J HAEMATOL, V51, P18

[9] ALLERGIC CROSS-REACTIVITY TO TEICOPLANIN AND VANCOMYCIN [J].

DAVENPORT, A .

NEPHRON, 1993, 63 (04) :482-482

[10] TEICOPLANIN IN THE TREATMENT OF INFECTIONS BY STAPHYLOCOCCI, CLOSTRIDIUM-DIFFICILE AND OTHER GRAM-POSITIVE BACTERIA [J].

DELALLA, F ;

SANTORO, D ;

RINALDI, E ;

SUTER, F ;

CRUCIANI, M ;

GUAGLIANONE, MH ;

RIZZARDINI, G ;

PELLEGATA, G .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (01) :131-142

← 1 2 3 4 5 6 →